The US Department of Veterans Affairs Science and Health Initiative to Combat Infectious and Emerging Life-Threatening Diseases (VA SHIELD): A Biorepository Addressing National Health Threats

Author:

Harley John B1,Pyarajan Saiju2ORCID,Partan Elizabeth S2ORCID,Epstein Lauren3ORCID,Wertheim Jason A4ORCID,Diwan Abhinav5ORCID,Woods Christopher W6ORCID,Davey Victoria7ORCID,Blair Sharlene1ORCID,Clark Dennis H1ORCID,Kaufman Kenneth M1ORCID,Khan Shagufta1,Chepelev Iouri1ORCID,Devine Alexander8ORCID,Cameron Perry9ORCID,McCann Monica F10ORCID,Ammons Mary Cloud B1112ORCID,Bolz Devin D11ORCID,Battles Jane K7ORCID,Curtis Jeffrey L13ORCID,Holodniy Mark14ORCID,Marconi Vincent C315ORCID,Searles Charles D3ORCID,Beenhouwer David O16ORCID,Brown Sheldon T17ORCID,Moorman Jonathan P1819ORCID,Yao Zhi Q1819,Rodriguez-Barradas Maria C2021ORCID,Mohapatra Shyam22ORCID,Molina De Rodriguez Osmara Y4ORCID,Padiernos Emerson B11ORCID,McIndoo Eric R1112ORCID,Price Emily1112ORCID,Burgoyne Hailey M1112ORCID,Robey Ian4ORCID,Schwenke Dawn C4ORCID,Shive Carey L23ORCID,Przygodzki Ronald M7ORCID,Ramoni Rachel B7ORCID,Krull Holly K7ORCID,Bonomo Robert A2324ORCID

Affiliation:

1. Research Services, US Department of Veterans Affairs Medical Center , Cincinnati, Ohio , USA

2. Center for Data and Computational Sciences, Veterans Affairs Boston Healthcare System , Boston, Massachusetts , USA

3. Infectious Diseases, US Department of Veterans Affairs Medical Center , Atlanta, Georgia , USA

4. Research & Development, Southern Arizona Veterans Affairs Healthcare System, US Department of Veterans Affairs , Tucson, Arizona , USA

5. Cardiology, Veterans Affairs Saint Louis Healthcare System, US Department of Veterans Affairs, Saint Louis, Missouri , USA

6. Medicine, US Department of Veterans Affairs Medical Center , Durham, North Carolina , USA

7. Office of Research and Development, US Department of Veterans Affairs , Washington, District of Columbia , USA

8. Prometheus Federal Services , Titan Alpha, Washington, District of Columbia , USA

9. Customer Value Partners , Titan Alpha, Washington, District of Columbia , USA

10. Office of Research and Development, Chesapeake Medical Communications, Contractor for the US Department of Veterans Affairs , Washington, District of Columbia , USA

11. Research, US Department of Veterans Affairs Medical Center , Boise, Idaho , USA

12. Idaho Veterans Research and Education Foundation , Boise, Idaho , USA

13. Medicine Service, Veteran Affairs Ann Arbor Healthcare System, US Department of Veterans Affairs , Ann Arbor, Michigan , USA

14. Public Health Surveillance, Veterans Affairs Palo Alto Healthcare System, US Department of Veterans Affairs , Palo Alto, California , USA

15. Division of Infectious Diseases, Emory School of Medicine and Rollins School of Public Health , Atlanta, Georgia , USA

16. Medicine, Veterans Affairs Greater Los Angeles Healthcare System, US Department of Veterans Affairs , Los Angeles, California , USA

17. Infectious Diseases, James J. Peters Veterans Affairs Medical Center, US Department of Veterans Affairs , Bronx, New York , USA

18. Infectious Diseases, James H. Quillen Veterans Affairs Medical Center, US Department of Veterans Affairs , Mountain Home, Tennessee , USA

19. Center of Excellence in Inflammation, Infectious Diseases, and Immunity, East Tennessee State University , Johnson City, Tennessee , USA

20. Infectious Diseases Section, Michael E. DeBakey Veterans Affairs Medical Center, US Department of Veterans Affairs , Houston, Texas , USA

21. Department of Medicine, Baylor College of Medicine , Houston, Texas , USA

22. Medicine, James A. Haley Veterans Hospital, US Department of Veterans Affairs , Tampa, Florida , USA

23. Medicine, Veterans Affairs Northeast Ohio Healthcare System, US Department of Veterans Affairs , Cleveland, Ohio , USA

24. Departments of Medicine, Pharmacology, & Molecular Biology and Microbiology, Case Western Reserve University , Cleveland, Ohio , USA

Abstract

Abstract Background The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has demonstrated the need to share data and biospecimens broadly to optimize clinical outcomes for US military Veterans. Methods In response, the Veterans Health Administration established VA SHIELD (Science and Health Initiative to Combat Infectious and Emerging Life-threatening Diseases), a comprehensive biorepository of specimens and clinical data from affected Veterans to advance research and public health surveillance and to improve diagnostic and therapeutic capabilities. Results VA SHIELD now comprises 12 sites collecting de-identified biospecimens from US Veterans affected by SARS-CoV-2. In addition, 2 biorepository sites, a data processing center, and a coordinating center have been established under the direction of the Veterans Affairs Office of Research and Development. Phase 1 of VA SHIELD comprises 34 157 samples. Of these, 83.8% had positive tests for SARS-CoV-2, with the remainder serving as contemporaneous controls. The samples include nasopharyngeal swabs (57.9%), plasma (27.9%), and sera (12.5%). The associated clinical and demographic information available permits the evaluation of biological data in the context of patient demographics, clinical experience and management, vaccinations, and comorbidities. Conclusions VA SHIELD is representative of US national diversity with a significant potential to impact national healthcare. VA SHIELD will support future projects designed to better understand SARS-CoV-2 and other emergent healthcare crises. To the extent possible, VA SHIELD will facilitate the discovery of diagnostics and therapeutics intended to diminish COVID-19 morbidity and mortality and to reduce the impact of new emerging threats to the health of US Veterans and populations worldwide.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3